These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3983671)

  • 1. Mexiletine therapy for ventricular tachycardia.
    Maddox RW; Arnold WS
    South Med J; 1985 Apr; 78(4):482-3. PubMed ID: 3983671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mexiletine in the treatment of lidocaine-resistant ventricular tachycardia. Preliminary results].
    Santinelli V; Chiariello M; Stanislao M; Turco P; Clarizia M; Condorelli M
    G Ital Cardiol; 1982; 12(6):457-9. PubMed ID: 7160572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine in lidocaine-resistant ventricular tachycardia.
    Abinader EG
    Am Heart J; 1984 Apr; 107(4):808-9. PubMed ID: 6702581
    [No Abstract]   [Full Text] [Related]  

  • 5. Mexiletine for treatment of sustained recurrent ventricular tachycardia.
    Santinelli V; Chiariello M; Stanislao M; Condorelli M
    Int J Cardiol; 1983; 2(3-4):443-5. PubMed ID: 6840912
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
    Breithardt G; Seipel L; Abendroth RR
    J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined mexiletine and propranolol treatment of refractory ventricular tachycardia.
    Leahey EB; Heissenbuttel RH; Giardina EG; Bigger JT
    Br Med J; 1980 Aug; 281(6236):357-8. PubMed ID: 7427278
    [No Abstract]   [Full Text] [Related]  

  • 9. Mexiletine: long-term follow-up of a patient with prolonged QT interval and quinidine-induced torsades de pointes.
    Thomas MG; Giles TD
    South Med J; 1985 Feb; 78(2):205-6. PubMed ID: 3919448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous mexiletine in management of lidocaine-resistant ventricular tachycardia.
    Santinelli V; Chiariello M; Stanislao M; Condorelli M
    Am Heart J; 1983 Apr; 105(4):680-5. PubMed ID: 6837421
    [No Abstract]   [Full Text] [Related]  

  • 11. Mexiletine for treatment of torsade de pointes.
    Shah A; Schwartz H
    Am Heart J; 1984 Mar; 107(3):589-91. PubMed ID: 6695705
    [No Abstract]   [Full Text] [Related]  

  • 12. [Severe ventricular arrhythmia in childhood treated with mexiletine].
    Milandri M; Rubboli F; Sorbello F; Morgagni GL; Aquilina M; Morgagni W
    Clin Ter; 1984 Jun; 109(5):467-70. PubMed ID: 6236938
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
    Manz M; Steinbeck G; Nitsch J; Lüderitz B
    Br Heart J; 1983 Mar; 49(3):222-8. PubMed ID: 6830659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
    G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mexiletine in the treatment of recurrent ventricular tachycardia. Prediction of long-term arrhythmia suppression from acute and short-term response.
    Wang RY; Lee PK; Wong KL; Chow MS
    J Clin Pharmacol; 1983; 23(2-3):89-92. PubMed ID: 6853747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine and tocainide: does response to one predict response to the other?
    Hession M; Blum R; Podrid PJ; Lampert S; Stein J; Lown B
    J Am Coll Cardiol; 1986 Feb; 7(2):338-43. PubMed ID: 3080508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine for ventricular arrhythmia after repair of tetralogy of Fallot.
    Malcolm I; Stubington D
    Can Med Assoc J; 1981 Dec; 125(12):1314-5. PubMed ID: 7326645
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical electrophysiological evaluation of mexiletine].
    Molina L; Colín L; Micheletti T; Blank S; Camacho J
    Arch Inst Cardiol Mex; 1986; 56(3):219-23. PubMed ID: 2944491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral mexiletine on left and right ventricular function.
    Stein J; Podrid P; Lown B
    Am J Cardiol; 1984 Sep; 54(6):575-8. PubMed ID: 6475776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of mexiletine in patients with ventricular tachycardia.
    Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
    Am Heart J; 1986 Jul; 112(1):14-9. PubMed ID: 3728269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.